Stillwater Capital Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-946
Closed -$332K 70
2025
Q4
$332K Hold
946
0.04% 62
2025
Q3
$306K Buy
+946
New +$294K 0.03% 62

Other funds holding ELV

Stillwater Capital Advisors's ELV Position: Q1 2026 in Review

Stillwater Capital Advisors sold out of Elevance Health (ELV) in Q1 2026, closing a stake of 946 shares — an estimated $332K sold.

Stillwater Capital Advisors first reported a position in ELV in Q3 2025 and held it in 2 quarters. The position peaked at $332K in Q4 2025. 1,462 funds tracked by Wall St. Rank hold ELV as of Q1 2026.

  • Stillwater Capital Advisors reported no remaining Elevance Health position as of Q1 2026 after selling out during the quarter.
  • Stillwater Capital Advisors sold 946 Elevance Health shares in Q1 2026, an estimated $332K.
  • Stillwater Capital Advisors first reported a position in Elevance Health in Q3 2025 and held it in 2 quarters.
  • Stillwater Capital Advisors's Elevance Health position peaked at $332K in Q4 2025.
  • 1,462 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.

Based on Stillwater Capital Advisors's 13F filing for Q1 2026, filed 10 Apr 2026.